Nine Square Therapeutics
PrivateLast Round
Grant
Sep 12, 2023
Total Funding Raised
$54.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nine Square Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Grant round in September 2023.
Nine Square Therapeutics is a biotechnology company that develops small-molecule therapeutics for neurodegenerative diseases by integrating machine-learning-enabled image-based cell profiling, chemistry, and computational sciences.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nine Square Therapeutics Comparables
Compare Nine Square Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Libra Therapeutics | 89% | |
| Lysoway Therapeutics | 87% | |
| Casma Therapeutics | 87% |
For institutional investors. Book with your work email.
Nine Square Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 12, 2023 | ||||
| Series A | Jul 1, 2020 |
For institutional investors. Book with your work email.
Nine Square Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 80% MoM.
- Sep 12, 2023
$5M grant from The Michael J. Fox Foundation
For institutional investors. Book with your work email.
Nine Square Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nine Square Therapeutics's valuation, stock price, and market status.
Is Nine Square Therapeutics a public or private company?
Nine Square Therapeutics is a private company.
What is the current stock price of Nine Square Therapeutics?
Nine Square Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nine Square Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nine Square Therapeutics worth (valuation)?
Valuation information for Nine Square Therapeutics is not publicly available.
Can I buy Nine Square Therapeutics stock?
Nine Square Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nine Square Therapeutics's last funding round?
Nine Square Therapeutics's most recent funding round was Grant on September 12, 2023.
Who are the main investors in Nine Square Therapeutics?
Key investors in Nine Square Therapeutics include Apple Tree Partners.
Will Nine Square Therapeutics IPO soon?
No public IPO plans have been announced for Nine Square Therapeutics.
How can I track Nine Square Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nine Square Therapeutics's shares on secondary markets.